Quantbot Technologies LP Anavex Life Sciences Corp. Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$4.55 - $6.75 $54,600 - $81,000	12,000 New	12,000 $61,000
Q4 2022 Feb 13, 2023	SELL	$7.65 - $14.43 $137,700 - $259,740	-18,000 Reduced 86.54%	2,800 $25,000
Q3 2022 Nov 07, 2022	BUY	$8.9 - $12.86 $128,177 - $185,209	14,402 Added 225.1%	20,800 $214,000
Q2 2022 Aug 09, 2022	BUY	$7.31 - $12.84 $46,769 - $82,150	6,398 New	6,398 $64,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $5,220 - $9,481	-536 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$16.88 - $23.31 $96,216 - $132,867	-5,700 Reduced 91.4%	536 $9,000
Q3 2021 Nov 09, 2021	BUY	$16.82 - $25.75 $79,659 - $121,952	4,736 Added 315.73%	6,236 $111,000
Q2 2021 Aug 12, 2021	BUY	$10.16 - $28.86 $15,240 - $43,290	1,500 New	1,500 $34,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $424M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.